Back to Search
Start Over
Presage Biosciences Announces First Patient Dosing of Pure Biologics' ROR1 Targeting Antibody For Treatment of Cancer
- Source :
- PR Newswire. July 25, 2024
- Publication Year :
- 2024
-
Abstract
- SEATTLE, July 25, 2024 /PRNewswire/ -- Presage Biosciences, a biotechnology company that directly measures activity of oncology drugs within human tumors, announced the Phase 0 dosing of the first cancer [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.802534612